Harmony Biosciences Holdings (HRMY) Leases (2020 - 2025)
Harmony Biosciences Holdings (HRMY) has disclosed Leases for 6 consecutive years, with $5.3 million as the latest value for Q4 2025.
- Quarterly Leases rose 151.84% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, up 151.84% year-over-year, with the annual reading at $5.3 million for FY2025, 151.84% up from the prior year.
- Leases hit $5.3 million in Q4 2025 for Harmony Biosciences Holdings, up from $1.2 million in the prior quarter.
- In the past five years, Leases ranged from a high of $5.3 million in Q4 2025 to a low of $1.2 million in Q3 2025.
- Historically, Leases has averaged $2.5 million across 5 years, with a median of $2.4 million in 2023.
- Biggest YoY gain for Leases was 151.84% in 2025; the steepest drop was 49.08% in 2025.
- Year by year, Leases stood at $3.3 million in 2021, then dropped by 29.9% to $2.3 million in 2022, then rose by 1.38% to $2.3 million in 2023, then dropped by 9.47% to $2.1 million in 2024, then skyrocketed by 151.84% to $5.3 million in 2025.
- Business Quant data shows Leases for HRMY at $5.3 million in Q4 2025, $1.2 million in Q3 2025, and $1.3 million in Q2 2025.